Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > RuBCG HUGE POTENTIAL

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Jul 11, 2024 4:15pm

152 Views

Post# 36129055

RE:RE:RE:RuBCG HUGE POTENTIAL

Once we have BTD for bladder cancer under our belts, our worth becomes in the billions because now we know the other indications we will be going for and that we have our compound approved, we becoome a major target for big pharma, until BTD, fingers crossed,would definitely like to see in 24 but will take early 25 if FDA plays games with us

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide